Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001209191-22-050258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-16 | 2022-09-14 | EWTX | Novo Holdings A/S | 10% | P - Purchase | $10.32 | +484.5K | 6.07M | +9% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2022-09-14 | P | A | 484,496 | $10.32 | 6,071,703 | D | — | — | (F1) Represents a purchase from the underwriters in the Issuer's public offering. |